Measles-containing-vaccine second-dose (MCV2) immunization coverage in Papua New Guinea
Papua New Guinea: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 28.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Papua New Guinea, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Papua New Guinea stood at 28.0%.
Compared with earlier readings it is up 7.7% on the previous year and up 3.7% over five years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Papua New Guinea peaked at 41.0% in 2023 and was at its lowest, 0.0%, in 2000.
That places Papua New Guinea 190th out of 194 countries with data for 2025, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Papua New Guinea, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 20.0% | — |
| 2020 | 27.0% | +35.0% |
| 2021 | 20.0% | -25.9% |
| 2022 | 25.0% | +25.0% |
| 2023 | 41.0% | +64.0% |
| 2024 | 26.0% | -36.6% |
| 2025 | 28.0% | +7.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 2.0% | 0.0% | 20.0% | 10 |
| 2020s | 27.8% | 20.0% | 41.0% | 6 |
Countries ranked near Papua New Guinea
- 187 Guinea-Bissau 36.0% compare
- 188 Nigeria 35.0% compare
- 189 Somalia 31.0% compare
- 191 Benin 23.0% compare
- 192 South Sudan 7.0% compare
- 193 Central African Republic 0.0%
- 193 Gabon 0.0%
More health data for Papua New Guinea
- Un projection of annual infant deaths, annual growth rate -1.77 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3741 % change on previous year (2090)
- Heat deaths vs projected death rates 1,127 (2090)
- Un projection of annual infant deaths 2,501 (2100)
- Population ages 0-14, female, annual growth rate 0.8327 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1596 units per person (2025)
- Population ages 0-14, male, annual growth rate 0.6669 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1718 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Papua New Guinea?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Papua New Guinea was 28.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Papua New Guinea?
- The highest recorded value was 41.0% in 2023.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Papua New Guinea?
- The lowest recorded value was 0.0% in 2000.
- How does Papua New Guinea rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Papua New Guinea ranks 190th out of 194 countries with data for 2025.
- Where does this Papua New Guinea data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).